11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome

MW O'Reilly, P Kempegowda… - The Journal of …, 2017 - academic.oup.com
The Journal of Clinical Endocrinology & Metabolism, 2017academic.oup.com
Context: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the
exact origin of hyperandrogenemia remains a matter of debate. Recent studies have
highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen
metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated
androgens to androgen excess in women with PCOS. Methods: One hundred fourteen
women with PCOS and 49 healthy control subjects underwent measurement of serum …
Context
Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS.
Methods
One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four–hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded.
Results
As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance.
Conclusions
We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.
Oxford University Press